This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kuo, M T
Right arrow Articles by Hittelman, W N
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kuo, M T
Right arrow Articles by Hittelman, W N

 Previous Article  |  Next Article 

Mol Cell Biol. 1994 August; 14(8): 5202-5211

Chromosome breakage at a major fragile site associated with P-glycoprotein gene amplification in multidrug-resistant CHO cells.

M T Kuo, R C Vyas, L X Jiang and W N Hittelman

Department of Molecular Pathology, University of Texas M. D. Anderson Cancer Center, Houston 77030.

ABSTRACT

Recent studies of several drug-resistant Chinese hamster cell lines suggested that a breakage-fusion-bridge mechanism is frequently involved in the amplification of drug resistance genes. These observations underscore the importance of chromosome breakage in the initiation of DNA amplification in mammalian cells. However, the mechanism of this breakage is unknown. Here, we propose that the site of chromosome breakage consistent with the initial event of P-glycoprotein (P-gp) gene amplification via the breakage-fusion-bridge cycle in three independently established multidrug-resistant CHO cells was located at 1q31. This site is a major chromosome fragile site that can be induced by methotrexate and aphidicolin treatments. Pretreatments of CHO cells with methotrexate or aphidicolin enhanced the frequencies of resistance to vinca alkaloid and amplification of the P-gp gene. These observations suggest that chromosome fragile sites play a pivotal role in DNA amplification in mammalian cells. Our data are also consistent with the hypothesis that gene amplification can be initiated by stress-induced chromosome breakage that is independent of modes of action of cytotoxic agents. Drug-resistant variants may arise by their growth advantage due to overproduction of cellular target molecules via gene amplification.

Mol Cell Biol. 1994 August; 14(8): 5202-5211




This article has been cited by other articles:

  • Preechapornkul, P., Imwong, M., Chotivanich, K., Pongtavornpinyo, W., Dondorp, A. M., Day, N. P. J., White, N. J., Pukrittayakamee, S. (2009). Plasmodium falciparum pfmdr1 Amplification, Mefloquine Resistance, and Parasite Fitness. Antimicrob. Agents Chemother. 53: 1509-1515 [Abstract] [Full Text]  
  • Ciullo, M., Debily, M.-A., Rozier, L., Autiero, M., Billault, A., Mayau, V., El Marhomy, S., Guardiola, J., Bernheim, A., Coullin, P., Piatier-Tonneau, D., Debatisse, M. (2002). Initiation of the breakage-fusion-bridge mechanism through common fragile site activation in human breast cancer cells: the model of PIP gene duplication from a break at FRA7I. Hum Mol Genet 11: 2887-2894 [Abstract] [Full Text]  
  • Huang, X., Gollin, S. M., Raja, S., Godfrey, T. E. (2002). High-resolution mapping of the 11q13 amplicon and identification of a gene, TAOS1, that is amplified and overexpressed in oral cancer cells. Proc. Natl. Acad. Sci. USA 99: 11369-11374 [Abstract] [Full Text]  
  • Mondello, C., Faravelli, M., Pipitone, L., Rollier, A., Di Leonardo, A., Giulotto, E. (2001). Gene amplification in fibroblasts from ataxia telangiectasia (AT) patients and in X-ray hypersensitive AT-like Chinese hamster mutants. Carcinogenesis 22: 141-145 [Abstract] [Full Text]  
  • Toledo, F., Coquelle, A., Svetlova, E., Debatisse, M. (2000). Enhanced flexibility and aphidicolin-induced DNA breaks near mammalian replication origins: implications for replicon mapping and chromosome fragility. Nucleic Acids Res 28: 4805-4813 [Abstract] [Full Text]  
  • Weisberg, E., Griffin, J. D. (2000). Mechanism of resistance to the ABL tyrosine kinase inhibitor STI571 in BCR/ABL-transformed hematopoietic cell lines. Blood 95: 3498-3505 [Abstract] [Full Text]  
  • Paulson, T. G., Almasan, A., Brody, L. L., Wahl, G. M. (1998). Gene Amplification in a p53-Deficient Cell Line Requires Cell Cycle Progression under Conditions That Generate DNA Breakage. Mol. Cell. Biol. 18: 3089-3100 [Abstract] [Full Text]  
  • Shimizu, N., Itoh, N., Utiyama, H., Wahl, G. M. (1998). Selective Entrapment of Extrachromosomally Amplified DNA by Nuclear Budding and Micronucleation during S Phase. JCB 140: 1307-1320 [Abstract] [Full Text]  
  • Palin, A., Critcher, R, Fitzgerald, D., Anderson, J., Farr, C. (1998). Direct cloning and analysis of DNA sequences from a region of the Chinese hamster genome associated with aphidicolin-sensitive fragility. J. Cell Sci. 111: 1623-1634 [Abstract]  
  • Linke, S P, Clarkin, K C, Di Leonardo, A, Tsou, A, Wahl, G M (1996). A reversible, p53-dependent G0/G1 cell cycle arrest induced by ribonucleotide depletion in the absence of detectable DNA damage.. Genes Dev. 10: 934-947 [Abstract]  
  • Torigoe, K, Sato, S, Kusaba, H, Kohno, K, Kuwano, M, Okumura, K, Green, E D, Tsui, L C, Scherer, S W, Schlessinger, D (1995). A YAC-based contig of 1.5 Mb spanning the human multidrug resistance gene region and delineating the amplification unit in three human multidrug-resistant cell lines.. Genome Res 5: 233-244 [Abstract]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»